CDMO extends spray drying capacity for aqueous and organic solvent-based formulations
Micro-Sphere adds GEA PSD-3 spray dryer in response to increased demand in spray drying.
CDMO, Micro-Sphere has added to its decades of GMP spray drying services with the addition of new spray drying technology.
A dedicated production area houses a GEA PSD-3 spray dryer, which will extend the CDMO’s spray drying capacity for both aqueous and organic solvent-based formulations.
The new equipment is part of the CDMO’s recently announced 21 million CHF (€19 million) investment into expanding its GMP manufacturing capabilities at its facility in Switzerland and comes in response to increased demand for spray drying from companies ranging from Big Pharma to small virtual firms.
Micro-Sphere Founder and President of the Board, Dr Michele Müller, said: “Customer demand for GMP spray drying is increasing and this latest investment strengthens our production capabilities while also reaffirming our niche expertise in the market.
“The market response to our investment in our facility in Switzerland has been excellent and we are now implementing the upgrades and changes needed to offer greater capacity to handle larger quantities of pharmaceutical powders and commercial volumes of finished dosage forms.”
GEA’s technology for Spray Drying is based near Copenhagen in Denmark, where GEA develops and manufactures spray drying systems and has comprehensive test facilities for pharmaceutical customers.
Søren Terp Madsen, Product Manager at GEA added: “This new unit is equipped with the best available solutions in terms of spraying systems and cyclone for powder recovery: it offers excellent process reliability and is a great choice for Micro-Sphere in line with its continued expansion. We’re delighted to be a part of their exciting future.”
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance